Gaddiel Galarza-Munoz

Title: Gaddiel Galarza-Munoz: Innovator in Autoimmune Disease and Cancer Therapy

Introduction

Gaddiel Galarza-Munoz is a prominent inventor based in Galveston, Texas. He has made significant contributions to the field of medical research, particularly in the development of therapies for autoimmune diseases and cancer. With a total of 6 patents to his name, Galarza-Munoz is recognized for his innovative approaches to complex medical challenges.

Latest Patents

One of Galarza-Munoz's latest patents focuses on a soluble interleukin-7 receptor (SIL7R) modulating therapy aimed at treating autoimmune diseases and cancer. This invention includes compositions and methods for treating these conditions in subjects in need. The method involves administering an effective amount of a composition that comprises an oligonucleotide specifically binding to a complementary sequence of the Interleukin-7 receptor (IL7R) pre-mRNA. This influences the splicing of exon 6, thereby affecting the expression of the soluble isoform of IL7R (sIL7R). In certain embodiments, the oligonucleotide can be an antisense oligonucleotide (ASO) or a splice-modulating antisense oligonucleotide (SM-ASO).

Career Highlights

Galarza-Munoz has worked with esteemed institutions such as the University of Texas System and Duke University. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Some of his notable coworkers include Mariano A Garcia-Blanco and Shelton S Bradrick. Their collaborative efforts have further enhanced the impact of Galarza-Munoz's research in the field.

Conclusion

Gaddiel Galarza-Munoz is a distinguished inventor whose work in modulating therapies for autoimmune diseases and cancer showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his dedication to improving patient outcomes through research and development.